Literature DB >> 29076874

Clear Cell Carcinoma of Salivary Glands Is Frequently p16 Positive: A Pitfall in the Interpretation of Oropharyngeal Biopsies.

Justin A Bishop1,2, Lisa M Rooper1, Simion I Chiosea3, William H Westra1.   

Abstract

Clear cell carcinoma (CCC) is a low-grade malignancy that commonly arises in minor salivary glands of the oropharynx and other sites. EWSR1-ATF1 gene fusions seem to be specific for this salivary neoplasm. Testing for EWSR1-ATF1 has expanded the histologic spectrum of CCC. As one important example, many CCCs have a predominantly squamous phenotype with few clear cells, a finding that can cause confusion with squamous cell carcinoma (SqCC). P16 immunohistochemical staining to determine human papillomavirus (HPV) status has become standard practice for all oropharyngeal carcinomas showing squamous differentiation. The purpose of this study was to determine whether this practice could contribute to the difficulty in distinguishing CCC from p16-positive SqCC. The authors' surgical pathology archives were searched for cases of CCC. All cases were evaluated with p16 immunohistochemistry, high-risk HPV RNA in situ hybridization (ISH), and EWSR1 gene break-apart fluorescence ISH. Sixteen CCCs were identified. All harbored an EWSR1 rearrangement. Eleven patients were women and 5 were men. They ranged in age from 30 to 85 years (mean, 58 y). The CCCs arose in the oropharynx (tongue base or tonsil) (n=8, 50%), oral cavity (n=4, 25%), and nasopharynx (n=4, 25%). Each case demonstrated clear cells, but the proportion was highly variable (10% to 90%, mean 48%), with 7 of 16 cases having <50% clear cells. Submitted diagnoses included SqCC (n=3) and mucoepidermoid carcinoma (n=2). Of the 3 patients diagnosed with SqCC, 1 was scheduled to undergo chemoradiation, and 1 had already completed chemoradiation. All 16 CCCs demonstrated p16 staining, with the percentage of p16-positive cells ranging from ≥70% (n=2), 50% to 69% (n=3), and 10% to 49% (n=11). Staining was cytoplasmic and nuclear. All cases were negative for high-risk HPV by RNA ISH. CCCs regularly show squamous features, often lack prominent clear cell changes, frequently arise in the oropharynx, and invariably show p16 staining. These features may cause confusion with SqCC, particularly HPV-related oropharyngeal SqCC. P16 staining is not to be taken as unequivocal evidence of an HPV-related SqCC, even for carcinomas showing squamous differentiation and originating in the oropharynx. Failure to recognize this pitfall could result in overly aggressive treatment of a low-grade carcinoma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29076874      PMCID: PMC5809298          DOI: 10.1097/PAS.0000000000000977

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  19 in total

1.  EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland.

Authors:  Cristina R Antonescu; Nora Katabi; Lei Zhang; Yun Shao Sung; Raja R Seethala; Richard C Jordan; Bayardo Perez-Ordoñez; Cherry Have; Sylvia L Asa; Iona T Leong; Grace Bradley; Hagen Klieb; Ilan Weinreb
Journal:  Genes Chromosomes Cancer       Date:  2011-04-11       Impact factor: 5.006

2.  Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists.

Authors:  James S Lewis; Beth Beadle; Justin A Bishop; Rebecca D Chernock; Carol Colasacco; Christina Lacchetti; Joel Todd Moncur; James W Rocco; Mary R Schwartz; Raja R Seethala; Nicole E Thomas; William H Westra; William C Faquin
Journal:  Arch Pathol Lab Med       Date:  2017-12-18       Impact factor: 5.534

3.  Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.

Authors:  Tatiana M Garcia-Bates; Eun Kim; Fernando Concha-Benavente; Sumita Trivedi; Robbie B Mailliard; Andrea Gambotto; Robert L Ferris
Journal:  J Immunol       Date:  2016-02-05       Impact factor: 5.422

4.  Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.

Authors:  Min-Shu Hsieh; Hsuang Wang; Yi-Hsuan Lee; Jenq-Yuh Ko; Yih-Leong Chang
Journal:  Hum Pathol       Date:  2016-10-18       Impact factor: 3.466

5.  Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene.

Authors:  Afrouz Behboudi; Fredrik Enlund; Marta Winnes; Ywonne Andrén; Anders Nordkvist; Ilmo Leivo; Emilie Flaberg; Laszlo Szekely; Antti Mäkitie; Reidar Grenman; Joachim Mark; Göran Stenman
Journal:  Genes Chromosomes Cancer       Date:  2006-05       Impact factor: 5.006

6.  Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.

Authors:  Joaquin J García; Jennifer L Hunt; Ilan Weinreb; Jonathan B McHugh; E Leon Barnes; Kathleen Cieply; Sanja Dacic; Raja R Seethala
Journal:  Hum Pathol       Date:  2011-07-20       Impact factor: 3.466

7.  Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.

Authors:  Matthew H Stenmark; Jonathan B McHugh; Matthew Schipper; Heather M Walline; Christine Komarck; Felix Y Feng; Francis P Worden; Gregory T Wolf; Douglas B Chepeha; Mark E Prince; Carol R Bradford; Suresh K Mukherji; Avraham Eisbruch; Thomas E Carey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-01       Impact factor: 7.038

8.  Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck.

Authors:  Marta Persson; Ywonne Andrén; Joachim Mark; Hugo M Horlings; Fredrik Persson; Göran Stenman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

9.  Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.

Authors:  Yoshitsugu Mitani; Bin Liu; Pulivarthi H Rao; Vishnupriya J Borra; Mark Zafereo; Randal S Weber; Merrill Kies; Guillermina Lozano; P Andrew Futreal; Carlos Caulin; Adel K El-Naggar
Journal:  Clin Cancer Res       Date:  2015-12-02       Impact factor: 12.531

10.  Novel PRKD gene rearrangements and variant fusions in cribriform adenocarcinoma of salivary gland origin.

Authors:  Ilan Weinreb; Lei Zhang; Laxmi M S Tirunagari; Yun-Shao Sung; Chun-Liang Chen; Bayardo Perez-Ordonez; Blaise A Clarke; Alena Skalova; Simion I Chiosea; Raja R Seethala; Daryl Waggott; Paul C Boutros; Christine How; Fei-Fei Liu; Jonathan C Irish; David P Goldstein; Ralph Gilbert; Nasir Ud Din; Adel Assaad; Jason L Hornick; Lester D R Thompson; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2014-06-18       Impact factor: 5.006

View more
  4 in total

Review 1.  Challenges in Minor Salivary Gland Biopsies: A Practical Approach to Problematic Histologic Patterns.

Authors:  Lisa M Rooper
Journal:  Head Neck Pathol       Date:  2019-03-18

2.  Human Papillomavirus (HPV)-Related Carcinoma of the Oropharynx with Squamous Cell and Adenoid Cystic Carcinoma-Like Features: Report of a Case.

Authors:  Christina K Hodgson; Rodrigo Bayon; Chris S Jensen; Robert A Robinson; Anand Rajan K D
Journal:  Head Neck Pathol       Date:  2020-10-13

3.  Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.

Authors:  Julia C Thierauf; Alex A Farahani; B Iciar Indave; Adam Z Bard; Valerie A White; Cameron R Smith; Hetal Marble; Martin D Hyrcza; John K C Chan; Justin Bishop; Qiuying Shi; Kim Ely; Abbas Agaimy; Maria Martinez-Lage; Vania Nose; Miguel Rivera; Valentina Nardi; Dora Dias-Santagata; Salil Garg; Peter Sadow; Long P Le; William Faquin; Lauren L Ritterhouse; Ian A Cree; A John Iafrate; Jochen K Lennerz
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

4.  Clinicopathological and molecular study of 10 salivary gland clear cell carcinomas, with emphasis on rare cases with high grade transformation and occurring in uncommon sites.

Authors:  Lanlan Xuan; Suxia Wang; Jianguo Wei; Jianwei Yuan; Honggang Liu
Journal:  Diagn Pathol       Date:  2022-01-30       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.